MolNFT v1 · #182910 · protein
Joint X-RAY/NEUTRON structure of SARS-cov-2 main protease (mpro) in complex with MCULE5948770040
7N8C · 3C-like proteinase: “Joint X-RAY/NEUTRON structure of SARS-cov-2 main protease (mpro) in complex with MCULE5948770040”. X-ray diffraction; neutron diffraction, 1 ligand (YD1), 2 pockets (best druggability 0.51). MolNFT v1 #182910 on…
- PDB
- 7N8C
- Type
- protein
- Length
- 306 residues
- Chains
- 1
- Method
- x-ray diffraction; neutron diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- 3C-like proteinase
- EC
- 3.4.22.69
- UniProt
- P0DTD1
- Ligands
- YD1
- Pockets
- 2 · best druggability 0.51
Structure
x-ray diffraction; neutron diffraction · 1 distinct chain · 24% helix, 28% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | 3C-like proteinase (EC 3.4.22.69) | protein | 306 | 24% helix, 28% strand | P0DTD1 |
Ligands and binding sites
- YD1 · 6-[4-(3,4-dichlorophenyl)piperazin-1-yl]carbonyl-1~{H}-pyrimidine-2,4-dione · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 196 | 0.51 | 0.77 | 30 | YD1 |
| 2 | 214 | 0.51 | 0.76 | 32 | empty |
Compared structures
- 7N8C · Joint X-ray/neutron structure of SARS-CoV-2 main protease (Mpro) in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0DTD1
- Elsewhere: RCSB PDB 7N8C · PDBe 7N8C · UniProt P0DTD1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.